• Return to Headlines

Biospecifics Tec Up 35.3% Since SmarTrend Uptrend Call (BSTC)

By David Diaz

SmarTrend identified an Uptrend for Biospecifics Tec (NASDAQ:BSTC) on March 12th, 2018 at $42.50. In approximately 8 months, Biospecifics Tec has returned 35.29% as of today's recent price of $57.50.

Biospecifics Tec share prices have moved between a 52-week high of $66.21 and a 52-week low of $38.05 and are now trading 51% above that low price at $57.50 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.5% while the 200-day MA has risen 0.8%.

BioSpecifics Technologies Corp. is a biopharmaceutical company. The Company developed and licensed injectable collagenase for the treatment of Dupuytren's disease, Peyronie's disease, and adhesive capsulitis (frozen shoulder).

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Biospecifics Tec shares.

Log in and add Biospecifics Tec (BSTC) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights biospecifics tec

Ticker(s): BSTC